HER2 (ErbB2 or NEU), a member of the ErbB family of receptor tyrosine kinases (RTKs), is the main pathogenic gene in breast cancer; HER2 overexpression has been demonstrated in 20 to 30% of patients [1, 2]. Here, EGFR is linked to breast cancer.